Urinary excretion of brush-border antigen revealed by monoclonal antibody: early indicator of toxic nephropathy

Lancet. 1985 Oct 26;2(8461):914-7. doi: 10.1016/s0140-6736(85)90850-5.

Abstract

Mouse monoclonal antibodies against brush-border antigens of the proximal tubule of human kidney were produced by the hybridisation technique. The urinary excretion of a brush-border protein with an apparent molecular weight of 50 000 (BB-50) was measured by a sandwich enzyme-linked immunosorbent assay with a mouse IgG1 against BB-50 and a polyclonal rabbit antiserum against human kidney as coating and second antibodies. The urinary excretion of BB-50 was fifty times higher in patients treated with cisplatin than in a matched control group and twice as high in workers occupationally exposed to water-soluble chromium(VI) compounds as in their matched controls. These findings suggest that the urinary excretion of kidney antigens revealed by monoclonal antibodies is a very sensitive and specific test for the assessment of toxic nephropathies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal*
  • Antigens / urine*
  • Chromium / poisoning*
  • Cisplatin / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Kidney Diseases / chemically induced
  • Kidney Diseases / diagnosis
  • Kidney Diseases / immunology*
  • Kidney Tubules, Proximal / immunology*
  • Male
  • Microvilli / immunology*
  • Middle Aged
  • Molecular Weight
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Occupational Diseases / chemically induced*
  • Occupational Diseases / immunology

Substances

  • Antibodies, Monoclonal
  • Antigens
  • Chromium
  • Cisplatin